Trugolf Holdings, Inc. current report, 31 March 2023

Vollständiges Dokument

Business Context and Reporting Period

Deep Medicine Acquisition Corp. filed this Form 8-K on March 31, 2023, under Item 7.01 (Regulation FD Disclosure) and Item 9.01. The filing announces a proposed business combination with TruGolf, Inc.; it does not report quarterly or annual operating results for TruGolf or Deep Medicine.

Transaction Overview

  • Deep Medicine entered into an Agreement and Plan of Merger with DMAC Merger Sub Inc., TruGolf, Inc., Bright Vision Sponsor LLC and Christopher Jones.
  • At closing, Merger Sub is expected to merge with and into TruGolf, with TruGolf surviving as a wholly owned subsidiary of Deep Medicine.
  • TruGolf equity holders are expected to receive shares of Deep Medicine common stock.
  • The parties issued a March 31, 2023 press release announcing execution of the merger agreement.

Financial Metrics and Liquidity

The filing does not provide clear values for revenue, net income, cash flow, margins, debt, cash balances, liquidity, valuation, purchase consideration or other operating metrics. It also does not provide financial statements for TruGolf or pro forma financial information for the proposed combined company.

Material Changes Versus Prior Period

The material change disclosed is the execution of the merger agreement and announcement of the proposed business combination. No comparable-period financial results or changes in operating performance are presented.

Outlook, Risks and Contingencies

  • Completion is subject to customary conditions, including approval by Deep Medicine stockholders, and may not occur or may not occur on the expected timetable.
  • The merger agreement may be terminated, and legal proceedings could affect the transaction.
  • The level of redemptions by Deep Medicine public stockholders could affect the transaction and the combined company’s available capital.
  • The filing identifies uncertainty regarding future revenue, capital expenditures, TruGolf’s market and industry opportunity, financial condition, liquidity, results of operations and expected benefits of the transaction.
  • Forward-looking statements are subject to risks described in future SEC filings, including the definitive proxy statement. The filing states that actual results may differ materially and that no assurance is given that the parties will achieve their expectations.
  • A preliminary and definitive proxy statement are expected to be filed with the SEC. Investors are urged to review those documents and related filings when available.

Important Facts to Verify

  • Whether the proposed merger receives required stockholder approval and satisfies all closing conditions.
  • The definitive transaction terms, exchange ratio, implied enterprise value and any financing arrangements disclosed in the proxy statement.
  • Expected public-stockholder redemptions and the resulting cash available to the combined company.
  • TruGolf’s audited financial statements, historical revenue and profitability, cash flow, debt and liquidity.
  • Any termination rights, closing deadlines, amendments, litigation or other material developments.
  • The final ownership structure, capitalization and trading symbol of the combined company.